Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study
Abstract Background The mutation of the KRAS (Kirsten rat sarcoma virus) gene is a prevalent genetic alteration in metastatic colorectal cancer (mCRC). According to previous research, this mutation significantly affects clinical outcomes and quality of life (QOL). This research investigated the asso...
Saved in:
Main Authors: | Fahmideh Bagrezaei, Bahram Pourghassem Gargari, Reza Eghdam Zamiri, Abdolrasoul Safaiyan, Mohammad Alizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13538-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort
by: Bryan F. Vaca-Cartagena, et al.
Published: (2025-02-01) -
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01) -
Knowledge and understanding of information after taking decision to participate or not in a randomized trial of surgery vs radiotherapy among patients with locally advanced prostate cancer – an observational study
by: Yvonne Brandberg, et al.
Published: (2025-01-01) -
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
by: Satoru Miyazaki, et al.
Published: (2025-02-01) -
The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)